Select language:  
1800 620 420
Close menu

PBAC recommends daratumumab for newly diagnosed AL amyloidosis

Daratumumab (Darzalex®) could be the first ever therapy to be approved in Australia for AL amyloidosis.

  • Amyloidosis
  • Treatments and side-effects
Read more
Daratumumab

New targeted treatment option available for Waldenström macroglobulinemia (WM) patients through PBS.

The Leukaemia Foundation has welcomed news that for the first time, a targeted treatment option will now be available for Waldenström macroglobulinemia (WM) patients through the Pharmaceutical Benefits Scheme (PBS).

  • Other blood cancers
  • Treatments and side-effects
Read more

Patients retain remission for 10+ years after CAR T-cell therapy

It’s 10 years since the first CLL patients were treated with CAR T-cell therapy and they are still in remission.

  • Chronic lymphocytic leukaemia
  • Treatments and side-effects
Read more
Illustration of various treatments, pills, medicines

Jane’s had three different cancer diagnoses in two years

  • Acute myeloid leukaemia
  • Myelodysplastic syndromes
  • Treatments and side-effects
Read more
Jane Alder and Violet

Expert Series: Prof. John Pimanda – lots of work is needed to improve long-term outcomes for MDS

  • Interviews with experts
  • Myelodysplastic syndromes
  • Treatments and side-effects
Read more

Katrina’s five-year delay in diagnosis was followed by a further wait for access to treatment.

  • Treatments and side-effects
Read more

Support for submission to MSAC for MRD testing reimbursement in ALL

  • Acute lymphoblastic leukaemia
  • Treatments and side-effects
Read more
Dr Peter Diamond

First CAR T-cell trial for myeloma a success for Andrew

Andrew was the first person in Western Australia to have the life-changing therapy.

  • Clinical trials
  • Myeloma
  • Treatments and side-effects
Read more
Andrew and Vivienne celebrating

New international trial for amyloidosis

In a first-ever Australian-French collaboration, an exciting new clinical trial, due to open before Christmas, will give Australians with relapsed or refractory AL amyloidosis access to a new drug combination. 

  • Amyloidosis
  • Clinical trials
  • Research
  • Treatments and side-effects
Read more
Illustration of various treatments, pills, medicines

Expert Series: Dr Piers Blombery on genomic testing

Dr Piers Blombery explains the basics of molecular testing which informs the treatment of blood cancer.   

  • Hodgkin lymphoma
  • Interviews with experts
  • Myeloma
  • Non-Hodgkin lymphoma
  • Research
  • Treatments and side-effects
Read more
Dr Piers Blombery